Connect with us

Health

Merck says study shows COVID-19 drug causes quick reduction in virus – Reuters

U.S. drugmaker Merck & Co Inc said on Saturday the experimental antiviral drug molnupiravir it is developing with Ridgeback Bio showed a quicker reduction in infectious…

Published

on

Article feature image
ADVERTISEMENT

By Reuters Staff
FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid
(Reuters) – U.S. drugmaker Merck & Co Inc said on Saturday the experimental antiviral drug molnupiravir it is developing with Ridgeback Bio showed a quicker reduction in infectious virus in its phase 2a study among participants with early COVID-19.
The secondary objective findings in this study, of a quicker decrease in infectious virus among…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
No Pregnancy Risk Found From 2 Covid-19 Vaccines, Preliminary Research Shows – The New York Times
Article feature image
Sinus-Clearing Foods That’ll Blast The Snot Right Out Of You – HuffPost
Article feature image
How vaccines are affecting Covid-19 outbreaks globally | World news – The Guardian